Financhill
Sell
12

IOVA Quote, Financials, Valuation and Earnings

Last price:
$3.53
Seasonality move :
-6.32%
Day range:
$3.52 - $3.66
52-week range:
$3.48 - $15.90
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.29x
P/B ratio:
1.64x
Volume:
10.1M
Avg. volume:
10.5M
1-year change:
-74.39%
Market cap:
$1.2B
Revenue:
$164.1M
EPS (TTM):
-$1.30

Earnings Data

Next earnings date for IOVA
May 09
2025
Most recent earnings per share
-$0.26
Beat by $0.01
(Feb 27/2025)
Consensus Estimate
-$0.27
(Feb 27/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

IOVA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/09/2025 Q1 $83.4M -- -- -$0.24 --
02/27/2025 Q4 $72.2M $73.7M -$0.26 -$0.27 $0.01
11/07/2024 Q3 $53.8M $58.6M -$0.28 -$0.30 $0.02
08/08/2024 Q2 $24.6M $31.1M -$0.34 -$0.35 $0.01
05/09/2024 Q1 $2.1M $715K -$0.42 -$0.41 -$0.01
02/28/2024 Q4 $1.4M $482K -$0.45 -$0.43 -$0.02
11/07/2023 Q3 -- -- -$0.46 -$0.46 -$0.00
08/08/2023 Q2 -- -- -$0.47 -$0.79 $0.32
05/09/2023 Q1 -- -- -$0.50 -$0.73 $0.23
02/28/2023 Q4 -- -- -$0.64 -$0.64 -$0.00
11/03/2022 Q3 -- -- -$0.63 -$0.64 $0.01
08/04/2022 Q2 -- -- -$0.63 -$0.61 -$0.02
05/05/2022 Q1 -- -- -$0.58 -- --
02/24/2022 Q4 -- -- -$0.63 -- --
11/04/2021 Q3 -- -- -$0.55 -- --
08/05/2021 Q2 -- -- -$0.53 -- --
05/06/2021 Q1 -- -- -$0.51 -- --
02/25/2021 Q4 -- -- -$0.47 -- --
11/05/2020 Q3 -- -- -$0.40 -- --
08/06/2020 Q2 -- -- -$0.47 -- --
05/05/2020 Q1 -- -- -$0.55 -- --
02/25/2020 Q4 -- -- -$0.50 -- --
11/04/2019 Q3 -- -- -$0.40 -- --
08/01/2019 Q2 -- -- -$0.38 -- --
05/07/2019 Q1 -- -- -$0.30 -- --
02/27/2019 Q4 -- -- -$0.27 -- --
11/06/2018 Q3 -- -- -$0.36 -- --
08/06/2018 Q2 -- -- -$0.34 -- --
05/10/2018 Q1 -- -- -$0.31 -- --
03/12/2018 Q4 -- -- -$0.36 -- --
10/31/2017 Q3 -- -- -$0.35 -- --
08/01/2017 Q2 -- -- -$0.37 -- --
05/01/2017 Q1 -- -- -$0.33 -- --
03/07/2017 Q4 -- -- -$0.25 -- --
11/04/2016 Q3 -- -- -$1.15 -- --
08/08/2016 Q2 -- -- -$0.23 -- --
03/31/2016 Q1 -- -- -$0.14 -- --
12/31/2015 Q4 -- -- -$0.20 -- --
09/30/2015 Q3 -- -- -$0.16 -- --
06/30/2015 Q2 -- -- -$0.14 -- --
03/31/2015 Q1 -- -- -$0.14 -- --

Iovance Biotherapeutics Earnings Questions

  • How Much did Iovance Biotherapeutics Generate in Revenue Last Quarter?

    Iovance Biotherapeutics reported $73.7M worth of top line sales in its most recent quarter.

  • Did Iovance Biotherapeutics Beat Earnings Last Quarter?

    Iovance Biotherapeutics announced earnings per share of -$0.26 which represents a beat of analyst forecast a -$0.27 per share.

  • Is Iovance Biotherapeutics Profitable?

    Iovance Biotherapeutics reported $28.2M that represents $0.09 per share over the last quarter.

  • What is the Analyst Consensus for Iovance Biotherapeutics EPS Next Year?

    Iovance Biotherapeutics's earnings are forecast to decrease from -$1.28 per share to -$1.29 per share next year representing a decrease of -37.59%.

  • When is Iovance Biotherapeutics's Earnings Date?

    Iovance Biotherapeutics's next earnings date is May 9, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Shopify a Millionaire Maker?
Is Shopify a Millionaire Maker?

Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…

Is Alphabet Stock No Longer a Good Bet?
Is Alphabet Stock No Longer a Good Bet?

Alphabet tripled its price per share over the past 5…

Pepsi Vs Coke Stock: Which Is Best?
Pepsi Vs Coke Stock: Which Is Best?

Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Sell
50
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Buy
82
EXOD alert for Mar 20

Exodus Movement [EXOD] is up 17.89% over the past day.

Buy
69
SIG alert for Mar 20

Signet Jewelers [SIG] is down 0.64% over the past day.

Sell
36
HQY alert for Mar 20

HealthEquity [HQY] is up 0.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock